STIL Stille AB (publ)

24.66USD250.50 SEK · STO-1.57%Mkt Cap: 221.55M USDP/E: 22.96

Stille AB (publ) develops, manufactures, and distributes medtech products in Sweden, Germany, the United Kingdom, Switzerland, North America, the United States, and internationally. It operates through the Surgical Instr…

Key Statistics

Company
Market Cap221.55M USD
Enterprise Value204.75M USD
Revenue (TTM)70.03M USD
Gross Profit28.34M USD
Net Income (TTM)5.48M USD
Revenue/Share7.79 USD
Last Price24.66 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees239
CountrySE
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINSE0000998650
Valuation
P/E (Trailing)22.96
P/E (Forward)20.62
PEG—
EV/EBITDA15.90
EV/Revenue2.92
P/S3.16
P/B2.78
EPS (TTM)1.07 USD
EPS (Forward)1.20 USD
52W Range
14.0877% of range27.86
52W High27.86 USD
52W Low14.08 USD
Profitability
Gross Margin50.73%
Oper. Margin15.75%
EBITDA Margin18.39%
Profit Margin9.81%
ROE7.86%
ROA5.28%
ROIC8.62%
ROCE8.87%
Growth
Revenue Growth22.90%
Earnings Growth2630.70%
Cash Flow & Leverage
Operating CF3.55M USD
CapEx (TTM)2.03M USD
FCF Margin2.70%
FCF Yield0.85%
Net Debt-16.80M USD
Net Debt/EBITDA-1.30
Net Debt/FCF-8.88
Balance Sheet
Debt/Equity0.17
Current Ratio3.54
Quick Ratio2.10
Book Value/Sh8.87 USD
Cash/Share1.87 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield1.16%
Payout Ratio0.00%
Ex-Div DateMay 8, 2023
Pay Date—
Splits
Last Split1:100
Split DateJun 24, 2008
Analyst Consensus
Rating—
Target (Mean)29.33 USD
Upside (mean)+19.0%
Target Range29.14 USD – 29.53 USD
29.14+19.0% to mean29.53
# Analysts2
Ownership
Shares Out.8.99M
Float4.84M
Insiders9.11%
Institutions79.75%
Technical
SMA 5024.73 (-0.3%)
SMA 20023.14 (+6.5%)
Beta0.30
S&P 52W Chg12.00%
Avg Vol (30d)11.98K
Avg Vol (10d)6.25K
Technical Indicators
RSI (14)46.4
MACD1.7318
MACD Signal2.0706
MACD Hist.-0.3388
BB Upper26.13 USD
BB Middle25.05 USD
BB Lower23.96 USD
BB Width8.66%
ATR (14)0.9639 USD
Vol Ratio (20d)0.29x

About Stille (STO: STIL)

›

Stille (STO: STIL) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 239 employees.

The shares were at 250.50 SEK on 19 November 2026, up 42.7% over 52 weeks. Its 52-week range is 143.00 SEK to 283.00 SEK: the price is 11.5% below the high and 75.2% above the low.

At a market capitalisation of 2.25B SEK, it trades at 23.0 times trailing earnings and 20.6 times forward earnings. The median trailing P/E of its 19 largest Medical Instruments & Supplies peers is 49.2, a discount of 53% for STIL.

Stille reports return on equity of 7.9%, an operating margin of 15.7% and revenue up 22.9% year over year.

It holds more cash than debt, a net cash position of 170.71M SEK. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 2 analysts cover the stock; their mean price target of 298.00 SEK is 19.0% above the current price.